|
1
|
Sanguinetti M, Posteraro B and Lass-Flörl
C: Antifungal drug resistance among Candida species:
Mechanisms and clinical impact. Mycoses. 58(Suppl 2): 2–13. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arendrup MC: Epidemiology of invasive
candidiasis. Curr Opin Crit Care. 16:445–452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Richards MJ, Edwards JR, Culver DH and
Gaynes RP: National Nosocomial Infections Surveillance System:
Nosocomial infections in coronary care units in the United States.
Am J Cardiol. 82:789–793. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pu Y, Liu A, Zheng Y and Ye B: In vitro
damage of Candida albicans biofilms by chitosan. Exp Ther
Med. 8:929–934. 2014.PubMed/NCBI
|
|
5
|
Schulze J and Sonnenborn U: Yeasts in the
gut: From commensals to infectious agents. Dtsch Arztebl Int.
106:837–842. 2009.PubMed/NCBI
|
|
6
|
Nenoff P, Krüger C, Schaller J,
Ginter-Hanselmayer G, Schulte-Beerbühl R and Tietz HJ: Mycology -
an update part 2: dermatomycoses: clinical picture and diagnostics.
J Dtsch Dermatol Ges. 12:749–777. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oliveira PM, Mascarenhas RE, Lacroix C,
Ferrer SR, Oliveira RP, Cravo EA, Alves AP and Grassi MF:
Candida species isolated from the vaginal mucosa of
HIV-infected women in Salvador, Bahia, Brazil. Braz J Infect Dis.
15:239–244. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dos Santos, Abrantes PM, McArthur CP and
Africa CW: Multi-drug resistant oral Candida species
isolated from HIV-positive patients in South Africa and Cameroon.
Diagn Microbiol Infect Dis. 79:222–227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ribeiro RAL, de Alencar Menezes TO, de
Melo Alves-Junior S, de Menezes SA, Marques-da-Silva SH and Rosário
Vallinoto AC: Oral carriage of Candida species in
HIV-infected patients during highly active antiretroviral therapy
(HAART) in Belém, Brazil. Oral Surg Oral Med Oral Pathol Oral
Radiol. 120:29–33. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun H, Chen Y, Zou X, Li H, Yin X, Qin H,
Liu R, Yu C, Li Q, Yu K, et al: Occurrence of oral Candida
colonization and its risk factors among patients with malignancies
in China. Clin Oral Investig. Jul 30–2015.(Epub ahead of print).
PubMed/NCBI
|
|
11
|
Tang J, Feng Y, Tsao S, Wang N, Curtain R
and Wang Y: Berberine and Coptidis rhizoma as novel
antineoplastic agents: A review of traditional use and biomedical
investigations. J Ethnopharmacol. 126:5–17. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu R, Zhang X, Zhang L, Gao X, Li H, Shi
J and Li X: Bitterness intensity prediction of berberine
hydrochloride using an electronic tongue and a GA-BP neural
network. Exp Ther Med. 7:1696–1702. 2014.PubMed/NCBI
|
|
13
|
Kobayashi Y, Yamashita Y, Fujii N,
Takaboshi K, Kawakami T, Kawamura M, Mizukami T and Nakano H:
Inhibitors of DNA topoisomerase I and II isolated from the Coptis
rhizomes. Planta Med. 61:414–418. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iwasa K, Kamigauchi M, Ueki M and
Taniguchi M: Antibacterial activity and structure-activity
relationships of berberine analogs. Eur J Med Chem. 31:469–478.
1996. View Article : Google Scholar
|
|
15
|
Kim SH, Lee SJ, Lee JH, Sun WS and Kim JH:
Antimicrobial activity of 9-O-acyl- and 9-O-alkylberberrubine
derivatives. Planta Med. 68:277–281. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park KD, Lee JH, Kim SH, Kang TH, Moon JS
and Kim SU: Synthesis of 13-(substituted benzyl) berberine and
berberrubine derivatives as antifungal agents. Bioorg Med Chem
Lett. 16:3913–3916. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gambari R, Hau DK, Wong WY and Chui CH:
Sensitization of Hep3B hepatoma cells to cisplatin and doxorubicin
by corilagin. Phytother Res. 28:781–783. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Darwish RM, Aburjai T, Al-Khalil S and
Mahafzah A: Screening of antibiotic resistant inhibitors from local
plant materials against two different strains of Staphylococcus
aureus. J Ethnopharmacol. 79:359–364. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang ZC, Wang BC, Yang XS, Wang Q and Ran
L: The synergistic activity of antibiotics combined with eight
traditional Chinese medicines against two different strains of
Staphylococcus aureus. Colloids Surf B Biointerfaces.
41:79–81. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mandal S, DebMandal M, Pal NK and Saha K:
DebMandal M, Pal NK and Saha K: Synergistic anti-Staphylococcus
aureus activity of amoxicillin in combination with Emblica
officinalis and Nymphae odorata extracts. Asian Pac J
Trop Dis. 3:711–714. 2010. View Article : Google Scholar
|
|
21
|
Mandal S, Mandal MD and Pal NK: Enhancing
chloramphenicol and trimethoprim in vitro activity by Ocimum
sanctum Linn. (Lamiaceae) leaf extract against
Salmonella enterica serovar Typhi. Asian Pac J Trop Med.
5:220–224. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bodiwala HS, Sabde S, Mitra D, Bhutani KK
and Singh IP: Synthesis of 9-substituted derivatives of berberine
as anti-HIV agents. Eur J Med Chem. 46:1045–1049. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
NCCLS. Reference Method for Broth Dilution
Antifungal Susceptibility Testing of Yeasts; Approved Standard
(2nd). National Committee for Clinical Laboratory Standards.
(Wayne, PA). M27-A2:2002.
|
|
24
|
Zhu J, Krom BP, Sanglard D, Intapa C,
Dawson CC, Peters BM, Shirtliff ME and Jabra-Rizk MA:
Farnesol-induced apoptosis in Candida albicans is mediated
by Cdr1-p extrusion and depletion of intracellular glutathione.
PLoS One. 6:e288302011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chung PY, Gambari R, Chen YX, Cheng CH,
Bian ZX, Chan AS, Tang JC, Leung PH, Chui CH and Lam KH:
Development of 8-benzyloxy-substituted quinoline ethers and
evaluation of their antimicrobial activities. Med Chem Res.
24:1568–1577. 2015. View Article : Google Scholar
|
|
26
|
Lam PL, Gambari R, Kok SH, Lam KH, Tang
JC, Bian ZX, Lee KK and Chui CH: Non-toxic agarose/gelatin-based
microencapsulation system containing gallic acid for antifungal
application. Int J Mol Med. 35:503–510. 2015.PubMed/NCBI
|
|
27
|
McClellan KJ, Wiseman LR and Markham A:
Terbinafine. An update of its use in superficial mycoses. Drugs.
58:179–202. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dhamgaye S, Devaux F, Vandeputte P,
Khandelwal NK, Sanglard D, Mukhopadhyay G and Prasad R: Molecular
mechanisms of action of herbal antifungal alkaloid berberine, in
Candida albicans. PLoS One. 9:e1045542014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wei GX, Xu X and Wu CD: In vitro synergism
between berberine and miconazole against planktonic and biofilm
Candida cultures. Arch Oral Biol. 56:565–572. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iwazaki RS, Endo EH, Ueda-Nakamura T,
Nakamura CV, Garcia LB and Filho BP: In vitro antifungal activity
of the berberine and its synergism with fluconazole. Antonie van
Leeuwenhoek. 97:201–205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Quan H, Cao YY, Xu Z, Zhao JX, Gao PH, Qin
XF and Jiang YY: Potent in vitro synergism of fluconazole and
berberine chloride against clinical isolates of Candida
albicans resistant to fluconazole. Antimicrob Agents Chemother.
50:1096–1099. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li DD, Xu Y, Zhang DZ, Quan H, Mylonakis
E, Hu DD, Li MB, Zhao LX, Zhu LH, Wang Y, et al: Fluconazole
assists berberine to kill fluconazole-resistant Candida
albicans. Antimicrob Agents Chemother. 57:6016–6027. 2013.
View Article : Google Scholar : PubMed/NCBI
|
